Immunotherapy before surgery shows promise for oral cancer
Disease control
Not yet recruiting
This study tests whether giving the immunotherapy drug nivolumab before surgery can shrink tumors in people with advanced oral cancer. About 60 adults with resectable oral squamous cell carcinoma will receive nivolumab, then have surgery. Researchers will also look for biomarkers…
Phase: PHASE2 • Sponsor: Prof. Lars Olaf Cardell • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC